Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maryann R Cooper

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 15, 2013
Reversible ageusia associated with romidepsin therapyMaryann R Cooper, Sara Brewer, Goran Broketa
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 20, 2014
Ado-trastuzumab emtansine for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancerKiki Chandni Patel, Kelly Hageman, Maryann R Cooper
The Annals of Pharmacotherapy|March 26, 2009
Efficacy and safety of modafinil in the treatment of cancer-related fatigueMaryann R Cooper, Heather M Bird, Michael Steinberg
American Journal of Pharmaceutical Education|November 4, 2022
Assessment of a Mindfulness Meditation Elective in an Accelerated Doctor of Pharmacy ProgramCheryl Durand, Maryann R Cooper, Carroll-Ann Goldsmith
The Annals of Pharmacotherapy|September 27, 2014
Ceritinib: a new tyrosine kinase inhibitor for non-small-cell lung cancerMaryann R Cooper, Helen Chim, Hoyi Chan, et al.
Oncotargets and Therapy|April 26, 2016
Profile of ramucirumab in the treatment of metastatic non-small-cell lung cancerMaryann R Cooper, Chelsea Binkowski, Jessica Hartung, et al.
American Journal of Therapeutics|May 4, 2018
Role of Immune Checkpoint Inhibitors in Small Cell Lung CancerMaryann R Cooper, Abdullah M Alrajhi, Cheryl R Durand
The Annals of Pharmacotherapy|December 5, 2013
Dosing of enoxaparin for venous thromboembolism prophylaxis in obese patientsKristine C Willett, Mohammad Alsharhan, Cheryl Durand, et al.
The Annals of Pharmacotherapy|June 20, 2013
The role of denosumab for prevention of skeletal-related complications in multiple myelomaKelly Hageman, Kiki Chandni Patel, Kimberly Mace, et al.
The Annals of Pharmacotherapy|August 25, 2011
Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropeniaMaryann R Cooper, Cheryl R Durand, Matthew T Beaulac, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 15, 2013
Reversible ageusia associated with romidepsin therapyMaryann R Cooper, Sara Brewer, Goran Broketa
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|March 20, 2014
Ado-trastuzumab emtansine for the treatment of human epidermal growth factor receptor 2-positive metastatic breast cancerKiki Chandni Patel, Kelly Hageman, Maryann R Cooper
The Annals of Pharmacotherapy|March 26, 2009
Efficacy and safety of modafinil in the treatment of cancer-related fatigueMaryann R Cooper, Heather M Bird, Michael Steinberg
American Journal of Pharmaceutical Education|November 4, 2022
Assessment of a Mindfulness Meditation Elective in an Accelerated Doctor of Pharmacy ProgramCheryl Durand, Maryann R Cooper, Carroll-Ann Goldsmith
The Annals of Pharmacotherapy|September 27, 2014
Ceritinib: a new tyrosine kinase inhibitor for non-small-cell lung cancerMaryann R Cooper, Helen Chim, Hoyi Chan, et al.
Oncotargets and Therapy|April 26, 2016
Profile of ramucirumab in the treatment of metastatic non-small-cell lung cancerMaryann R Cooper, Chelsea Binkowski, Jessica Hartung, et al.
American Journal of Therapeutics|May 4, 2018
Role of Immune Checkpoint Inhibitors in Small Cell Lung CancerMaryann R Cooper, Abdullah M Alrajhi, Cheryl R Durand
The Annals of Pharmacotherapy|December 5, 2013
Dosing of enoxaparin for venous thromboembolism prophylaxis in obese patientsKristine C Willett, Mohammad Alsharhan, Cheryl Durand, et al.
The Annals of Pharmacotherapy|June 20, 2013
The role of denosumab for prevention of skeletal-related complications in multiple myelomaKelly Hageman, Kiki Chandni Patel, Kimberly Mace, et al.
The Annals of Pharmacotherapy|August 25, 2011
Single-agent, broad-spectrum fluoroquinolones for the outpatient treatment of low-risk febrile neutropeniaMaryann R Cooper, Cheryl R Durand, Matthew T Beaulac, et al.
Pageof 2